Xunfei Healthcare’s Major Shareholders Voluntarily Extend Lock-Up to 2026

Xunfei Healthcare Technology Co., Ltd. ( (HK:2506) ) has issued an update.

Xunfei Healthcare Technology Co., Ltd. announced that several key shareholders, including controlling shareholder iFlytek Co., Ltd., venture capital investor Anhui Kexun Venture Capital Fund Partnership, and multiple management- and employee-related partnerships and individuals, have voluntarily extended the lock-up period on their holdings. These shareholders, who collectively own 52.76 million H shares (68.25% of the company’s H-share capital) and 88.07 million total shares (72.86% of the company’s total share capital), have committed not to reduce any of their holdings from the end of the original 12‑month post-listing lock-up on 29 December 2025 through 29 December 2026. The move signals strong confidence from core stakeholders in the company’s long-term prospects and is likely to support share price stability and market perception by limiting potential sell-down pressure after the initial lock-up expiry.

The most recent analyst rating on (HK:2506) stock is a Buy with a HK$143.59 price target. To see the full list of analyst forecasts on Xunfei Healthcare Technology Co., Ltd. stock, see the HK:2506 Stock Forecast page.

More about Xunfei Healthcare Technology Co., Ltd.

Xunfei Healthcare Technology Co., Ltd. is a Hong Kong-listed joint stock company incorporated in the People’s Republic of China, operating in the healthcare technology sector. The company is associated with iFlytek Co., Ltd., a major shareholder, and its capital structure includes both H shares listed in Hong Kong and unlisted domestic shares held by strategic and employee-partner investors.

Average Trading Volume: 115,549

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$5.57B

For an in-depth examination of 2506 stock, go to TipRanks’ Overview page.